Beyond Financial Statements From 2010 to 2026

DOCKF Stock  USD 0.16  0  2.94%   
Beyond Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Beyond Medical's valuation are provided below:
Gross Profit
-250.5 K
Market Capitalization
11.6 M
Enterprise Value Revenue
0.3417
Revenue
-21.9 K
Earnings Share
(0.07)
There are over one hundred nineteen available fundamental signals for Beyond Medical Technologies, which can be analyzed over time and compared to other ratios. Active traders should verify all of Beyond Medical Technologies prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The Beyond Medical's current Market Cap is estimated to increase to about 261.8 K. The Beyond Medical's current Enterprise Value is estimated to increase to about 306 K
Check Beyond Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Beyond Medical's main balance sheet or income statement drivers, such as Discontinued Operations of 122.5 K, Interest Expense of 7.9 K or Interest Income of 6 K, as well as many indicators such as Price To Sales Ratio of 3.49, Dividend Yield of 0.0 or Days Sales Outstanding of 11.75. Beyond financial statements analysis is a perfect complement when working with Beyond Medical Valuation or Volatility modules.
  
Build AI portfolio with Beyond Stock
Check out the analysis of Beyond Medical Correlation against competitors.

Beyond Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities372.9 K729.6 K386.2 K
Slightly volatile
Accounts Payable98.7 K85.8 K120 K
Pretty Stable
Total Current Assets11.8 K12.4 K1.1 M
Very volatile
Common Stock17 M27.1 M12.3 M
Slightly volatile
Property Plant Equipment125.1 K131.6 K258.1 K
Very volatile
Total Assets11.8 K12.4 K3.7 M
Slightly volatile
Other Current Liabilities89.9 K108.9 K67.9 K
Slightly volatile
Cash11.3 K11.9 K2.7 M
Slightly volatile
Other Assets26.1 K27.4 K236.1 K
Slightly volatile
Common Stock Shares Outstanding6.8 M7.1 M29.2 M
Slightly volatile
Other Current Assets1.1 K1.2 K208.6 K
Slightly volatile
Other Stockholder Equity2.7 M3.7 M2.6 M
Slightly volatile
Total Liabilities398.1 K729.6 K285.5 K
Slightly volatile
Deferred Long Term Liabilities460.9 K497.3 K425.3 K
Slightly volatile
Short Term Investments395.4 K416.2 K1.9 M
Slightly volatile
Capital Stock23.8 M27.1 M20.3 M
Slightly volatile
Property Plant And Equipment Net24.7 K26 K291.5 K
Slightly volatile
Property Plant And Equipment Gross719.7 K788.8 K610 K
Slightly volatile
Non Currrent Assets Other32.3 K33.2 K29.3 K
Slightly volatile
Short and Long Term Debt49.5 K69 K35.2 K
Slightly volatile
Net Debt37.4 K42.1 K46 K
Slightly volatile

Beyond Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Discontinued Operations122.5 K137.8 K150.5 K
Slightly volatile
Interest IncomeK6.3 K11.9 K
Pretty Stable
Selling General Administrative94.2 K99.2 K1.5 M
Slightly volatile
Total Operating Expenses375.3 K395.1 K1.8 M
Slightly volatile
Reconciled Depreciation96.7 K73.2 K49.6 K
Slightly volatile
Research Development85.7 K99.2 K172.9 K
Slightly volatile

Beyond Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation83.1 K73.2 K48.3 K
Slightly volatile
End Period Cash Flow11.3 K11.9 K786.3 K
Very volatile
Change To Netincome896.8 K944 K4.3 M
Slightly volatile
Begin Period Cash Flow54.8 K57.7 K792.8 K
Pretty Stable
Other Non Cash Items351.6 K370.1 K3.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.493.6818.0954
Slightly volatile
Days Sales Outstanding11.7512.37114
Slightly volatile
Average Payables60.4 K89.7 K70.7 K
Slightly volatile
Stock Based Compensation To Revenue0.0960.190.0887
Slightly volatile
Capex To Depreciation0.430.4532.2 K
Slightly volatile
EV To Sales1.932.0416.1476
Slightly volatile
Inventory Turnover3.53.331.4562
Slightly volatile
Days Of Inventory On Hand10811318.2 K
Slightly volatile
Payables Turnover6.466.162.5777
Slightly volatile
Sales General And Administrative To Revenue0.640.673.1962
Slightly volatile
Average Inventory105 K145.1 K127.4 K
Slightly volatile
Research And Ddevelopement To Revenue0.02420.02540.1549
Slightly volatile
Capex To Revenue0.07870.08290.7525
Slightly volatile
Cash Per Share0.00180.00195.3423
Pretty Stable
Days Payables Outstanding58.361.3713 K
Slightly volatile
Income Quality0.610.350.5971
Slightly volatile
Intangibles To Total Assets0.01090.01220.0133
Slightly volatile
Current Ratio0.01860.01967.5985
Very volatile
Receivables Turnover32.0730.5413.0588
Slightly volatile
Capex Per Share0.00990.01043.2094
Slightly volatile
Average Receivables29.5 K28.1 K21.9 K
Slightly volatile
Revenue Per Share0.06770.110.0684
Slightly volatile
Interest Debt Per Share0.00830.00870.0606
Slightly volatile
Debt To Assets4.113.910.8075
Slightly volatile
Operating Cycle11912618.3 K
Slightly volatile
Days Of Payables Outstanding58.361.3713 K
Slightly volatile
Ebt Per Ebit0.910.966.7381
Pretty Stable
Quick Ratio0.01860.01967.4081
Very volatile
Net Income Per E B T9.0E-49.0E-40.8394
Very volatile
Cash Ratio0.01780.01885.7333
Very volatile
Days Of Inventory Outstanding10811318.2 K
Slightly volatile
Days Of Sales Outstanding11.7512.37114
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.151.213.1226
Slightly volatile
Fixed Asset Turnover7.797.423.0545
Slightly volatile
Debt Ratio4.113.910.8075
Slightly volatile
Price Sales Ratio3.493.6818.0954
Slightly volatile
Asset Turnover0.240.430.2263
Slightly volatile

Beyond Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap261.8 K249.3 K191.5 K
Slightly volatile
Enterprise Value306 K291.4 K216.4 K
Slightly volatile

About Beyond Medical Financial Statements

Beyond Medical stakeholders use historical fundamental indicators, such as Beyond Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Beyond Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Beyond Medical's assets and liabilities are reflected in the revenues and expenses on Beyond Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Beyond Medical Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue638.3 K531.6 K
Stock Based Compensation To Revenue 0.19  0.10 
Sales General And Administrative To Revenue 0.67  0.64 
Research And Ddevelopement To Revenue 0.03  0.02 
Capex To Revenue 0.08  0.08 
Revenue Per Share 0.11  0.07 
Ebit Per Revenue(1.40)(1.47)

Currently Active Assets on Macroaxis

When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:
Check out the analysis of Beyond Medical Correlation against competitors.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.07)
Revenue Per Share
(0)
Quarterly Revenue Growth
(0.92)
Return On Assets
(0.20)
Return On Equity
(3.14)
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.